Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione for colon cancer

glutathione for colon cancer AKR1C1 interacts with STAT3 to increase intracellular and confers resistance to oxaliplatin in colorectal Protein S-glutathionylation induced by hypoxia

Protein S glutathionylation induced by hypoxia increases hypoxia inducible factor 1 in human colon cancer cells ScienceDirect Mollugin suppresses proliferation and drives ferroptosis of colorectal cancer cells through inhibition of insulin like growth factor 2 mRNA binding protein 3 glutathione peroxidase 4 axis ScienceDirect Frontiers Comprehensive review of the resistance mechanisms of colorectal cancer classified by therapy type Glutathione depleted cyclodextrin pseudo polyrotaxane nanoparticles for anti inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer therapy ScienceDirect Immunohistochemistry staining results of IgG, IgG1, and glutathione Download Scientific Diagram

SKU: 9469281191 · From lagence-mr.com

4.9
USD26.65 USD68.65

Pay in 4 interest-free payments of $6.66 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

C., Iaccarino, G., Blain, H., & Fiocchi, A

glutathione for colon cancer AKR1C1 interacts with STAT3 to increase intracellular and confers resistance to oxaliplatin in colorectal Protein S-glutathionylation induced by hypoxia

The resolution of ascites was significantly better in Alb3.0 vs

glutathione for colon cancer AKR1C1 interacts with STAT3 to increase intracellular and confers resistance to oxaliplatin in colorectal Protein S-glutathionylation induced by hypoxia

The table below provides a quick comparison

glutathione for colon cancer AKR1C1 interacts with STAT3 to increase intracellular and confers resistance to oxaliplatin in colorectal Protein S-glutathionylation induced by hypoxia

Children GLUTIOX 600 INJECTION 1 is meant for adult use

glutathione for colon cancer AKR1C1 interacts with STAT3 to increase intracellular and confers resistance to oxaliplatin in colorectal Protein S-glutathionylation induced by hypoxia

Intern Emerg Med 10(1):93102 Alwan A (2011) Global status report on noncommunicable diseases 2010

glutathione for colon cancer AKR1C1 interacts with STAT3 to increase intracellular and confers resistance to oxaliplatin in colorectal Protein S-glutathionylation induced by hypoxia
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Frontiers

US$ 24.30

4.6 (17 reviews)

recommand products